[/vc_column_text][vc_column_text][/vc_column_text][/vc_column][/vc_row]
Neurol Res Pract , 2 , 33
doi:10.1097/CRD.0000000000000513 Lau DCW, Erichsen L, Francisco AM, et al
A recent analysis of FDA adverse event reporting system (FAERS) data from 2004 to 2020 revealed a notable association between GLP-1 RAs and malignant pancreatic neoplasms (proportional reporting ratio [PRR], 9.86) [52]
Mice with inflammatory bowel disease healed within days of orally ingesting the peptide
The MB System aligns with this perspective by supporting the body's natural ability to regulate metabolism, gut health, and hormone functionkey factors in long-term health.* The research that is emerging on all the positive health benefits of the GLP-1 hormone continues to excite us, said Lisa Barnes, Vice President of Research & Development and Regulatory at LifeVantage